Our top pick for
Building a portfolio
Arcadia Biosciences, Inc is an agricultural inputs business based in the US. Arcadia Biosciences shares (RKDA) are listed on the NASDAQ and all prices are listed in US Dollars. Arcadia Biosciences employs 58 staff and has a trailing 12-month revenue of around USD$8 million.
|52-week range||USD$2.26 - USD$6.4|
|50-day moving average||USD$2.9066|
|200-day moving average||USD$3.0327|
|Wall St. target price||USD$7.53|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.942|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|Revenue TTM||USD$8 million|
|Gross profit TTM||USD$-814,000|
|Return on assets TTM||-26.92%|
|Return on equity TTM||-32.68%|
|Market capitalisation||USD$57.8 million|
TTM: trailing 12 months
There are currently 1.1 million Arcadia Biosciences shares held short by investors – that's known as Arcadia Biosciences's "short interest". This figure is 6.4% up from 993,104 last month.
There are a few different ways that this level of interest in shorting Arcadia Biosciences shares can be evaluated.
Arcadia Biosciences's "short interest ratio" (SIR) is the quantity of Arcadia Biosciences shares currently shorted divided by the average quantity of Arcadia Biosciences shares traded daily (recently around 1.3 million). Arcadia Biosciences's SIR currently stands at 0.82. In other words for every 100,000 Arcadia Biosciences shares traded daily on the market, roughly 820 shares are currently held short.
However Arcadia Biosciences's short interest can also be evaluated against the total number of Arcadia Biosciences shares, or, against the total number of tradable Arcadia Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Arcadia Biosciences's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Arcadia Biosciences shares in existence, roughly 50 shares are currently held short) or 0.0525% of the tradable shares (for every 100,000 tradable Arcadia Biosciences shares, roughly 53 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Arcadia Biosciences.
Find out more about how you can short Arcadia Biosciences stock.
We're not expecting Arcadia Biosciences to pay a dividend over the next 12 months.
Arcadia Biosciences's shares were split on a 1:20 basis on 23 January 2018. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Arcadia Biosciences shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Arcadia Biosciences shares which in turn could have impacted Arcadia Biosciences's share price.
Over the last 12 months, Arcadia Biosciences's shares have ranged in value from as little as $2.26 up to $6.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Arcadia Biosciences's is -0.7297. This would suggest that Arcadia Biosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Arcadia Biosciences has bucked the trend.
Arcadia Biosciences, Inc., a consumer-driven agricultural technology company, engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; nutritional oils; and HB4, a drought and herbicide tolerant soybean trait. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Canada, Africa, and India. The company was founded in 2002 and is headquartered in Davis, California.
Steps to owning and managing SGLB, with 24-hour and historical pricing before you buy.
Steps to owning and managing SSD, with 24-hour and historical pricing before you buy.
Steps to owning and managing SQNS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SFL, with 24-hour and historical pricing before you buy.
Steps to owning and managing AIHS, with 24-hour and historical pricing before you buy.
Steps to owning and managing ST, with 24-hour and historical pricing before you buy.
Steps to owning and managing SLCT, with 24-hour and historical pricing before you buy.
Steps to owning and managing EYES, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBSW, with 24-hour and historical pricing before you buy.
Steps to owning and managing SHG, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.